GeneDx Holdings Corp. (WGS) stock
WGSNasdaqServices-Health ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/3058% above fair value
$51.02−1.35 (-2.58%)
Close on Nov 16, 2026Market cap $1.52BP/E –Yield –
GeneDx operating margin
Operating margin is operating income as a percentage of revenue.
GeneDx's operating margin for the twelve months ending Jun 30, 2026 was -20.3%. For fiscal 2025 it was -3.1%, against -7.6% the year before. The highest annual figure on record is -3.1% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -3.1% | +4.5 |
| FY2024 | Dec 31, 2024 | -7.6% | +81.6 |
| FY2023 | Dec 31, 2023 | -89.2% | +195.3 |
| FY2022 | Dec 31, 2022 | -284.5% | −74.2 |
| FY2021 | Dec 31, 2021 | -210.3% | −75.3 |
| FY2020 | Dec 31, 2020 | -134.9% | −119.4 |
| FY2019 | Dec 31, 2019 | -15.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -15.3% | −24.0 |
| Q1 FY2026 | Mar 31, 2026 | -56.2% | −51.0 |
| Q4 FY2025 | Dec 31, 2025 | -11.8% | −21.0 |
| Q3 FY2025 | Sep 30, 2025 | -2.8% | +7.3 |
| Q2 FY2025 | Jun 30, 2025 | 8.7% | +23.7 |
| Q1 FY2025 | Mar 31, 2025 | -5.2% | +16.7 |
| Q4 FY2024 | Dec 31, 2024 | 9.2% | +53.9 |
| Q3 FY2024 | Sep 30, 2024 | -10.1% | +70.5 |
| Q2 FY2024 | Jun 30, 2024 | -15.0% | +91.0 |
| Q1 FY2024 | Mar 31, 2024 | -21.9% | +118.0 |
| Q4 FY2023 | Dec 31, 2023 | -44.7% | +484.9 |
| Q3 FY2023 | Sep 30, 2023 | -80.6% | +28.5 |
| Q2 FY2023 | Jun 30, 2023 | -106.0% | +343.7 |
| Q1 FY2023 | Mar 31, 2023 | -139.9% | +25.6 |
| Q4 FY2022 | Dec 31, 2022 | -529.6% | −329.2 |
| Q3 FY2022 | Sep 30, 2022 | -109.1% | +95.3 |
| Q2 FY2022 | Jun 30, 2022 | -449.7% | −353.0 |
| Q1 FY2022 | Mar 31, 2022 | -165.6% | +140.8 |
| Q4 FY2021 | Dec 31, 2021 | -200.3% | −4.8 |
| Q3 FY2021 | Sep 30, 2021 | -204.4% | −59.3 |
| Q2 FY2021 | Jun 30, 2021 | -96.7% | +16.8 |
| Q1 FY2021 | Mar 31, 2021 | -306.3% | −248.9 |
| Q4 FY2020 | Dec 31, 2020 | -195.5% | – |
| Q3 FY2020 | Sep 30, 2020 | -145.1% | – |
| Q2 FY2020 | Jun 30, 2020 | -113.5% | – |
| Q1 FY2020 | Mar 31, 2020 | -57.4% | – |
See a number that looks wrong?